<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Droho S</submitter><funding>National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>NIAID NIH HHS</funding><funding>Rheumatology Research Foundation</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>Northwestern University</funding><funding>Lupus Research Alliance</funding><funding>National Institute on Aging</funding><funding>United States-Israel Binational Science Foundation</funding><funding>NEI NIH HHS</funding><funding>National Eye Institute</funding><funding>Research to Prevent Blindness</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>e168142</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10132149</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(7)</volume><pubmed_abstract>Patients with neovascular AMD (nAMD) suffer vision loss from destructive angiogenesis, termed choroidal neovascularization (CNV). Macrophages are found in CNV lesions from patients with nAMD. Additionally, Ccr2-/- mice, which lack classical monocyte-derived macrophages, show reduced CNV size. However, macrophages are highly diverse cells that can perform multiple functions. We performed single-cell RNA-Seq on immune cells from WT and Ccr2-/- eyes to uncover macrophage heterogeneity during the laser-induced CNV mouse model of nAMD. We identified 12 macrophage clusters, including Spp1+ macrophages. Spp1+ macrophages were enriched from WT lasered eyes and expressed a proangiogenic transcriptome via multiple pathways, including vascular endothelial growth factor signaling, endothelial cell spr</pubmed_abstract><journal>JCI insight</journal><pubmed_title>CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization.</pubmed_title><pmcid>PMC10132149</pmcid><funding_grant_id>AG049665</funding_grant_id><funding_grant_id>EY030923</funding_grant_id><funding_grant_id>Unrestricted Departmental Grant</funding_grant_id><funding_grant_id>UH2 AR067687</funding_grant_id><funding_grant_id>UH2AR067687</funding_grant_id><funding_grant_id>HL134375</funding_grant_id><funding_grant_id>Agmt 05/06/14</funding_grant_id><funding_grant_id>Rheumatology Precision Medicine Fund</funding_grant_id><funding_grant_id>Dixon Translational Research Grant Initiative Award</funding_grant_id><funding_grant_id>Novel Research Grant</funding_grant_id><funding_grant_id>Innovative Research Award</funding_grant_id><funding_grant_id>P30 CA060553</funding_grant_id><funding_grant_id>Sybil B. Harrington Career Development Award for Macular Degeneration</funding_grant_id><funding_grant_id>R01 AI170938</funding_grant_id><funding_grant_id>K08 EY030923</funding_grant_id><funding_grant_id>CA060553</funding_grant_id><funding_grant_id>AR064546</funding_grant_id><funding_grant_id>2013247</funding_grant_id><pubmed_authors>Rajesh A</pubmed_authors><pubmed_authors>Lavine JA</pubmed_authors><pubmed_authors>Droho S</pubmed_authors><pubmed_authors>Perlman H</pubmed_authors><pubmed_authors>Cuda CM</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD11c+ macrophages are proangiogenic and necessary for experimental choroidal neovascularization.</name><description>Patients with neovascular AMD (nAMD) suffer vision loss from destructive angiogenesis, termed choroidal neovascularization (CNV). Macrophages are found in CNV lesions from patients with nAMD. Additionally, Ccr2-/- mice, which lack classical monocyte-derived macrophages, show reduced CNV size. However, macrophages are highly diverse cells that can perform multiple functions. We performed single-cell RNA-Seq on immune cells from WT and Ccr2-/- eyes to uncover macrophage heterogeneity during the laser-induced CNV mouse model of nAMD. We identified 12 macrophage clusters, including Spp1+ macrophages. Spp1+ macrophages were enriched from WT lasered eyes and expressed a proangiogenic transcriptome via multiple pathways, including vascular endothelial growth factor signaling, endothelial cell spr</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2026-05-29T06:36:15.481Z</modification><creation>2025-02-19T02:03:57.06Z</creation></dates><accession>S-EPMC10132149</accession><cross_references><pubmed>36821388</pubmed><doi>10.1172/jci.insight.168142</doi></cross_references></HashMap>